"compound 25"-2
RORγt allosteric inhibitor Orally bioavailable in higher species from HTS and ligand-based design ACS Med. Chem. Lett. 11, 114-119 Merck, Boston, MA
Molecules of the Month - February 2020
Molecules of the Month
- LNP023
- LMB763 (nidufexor)
- ABBV-744
- AG-881
- FT-2102 (olutasidenib)
- GS-9876 (lanraplenib)
- "compound 25"
- "compound 25"-2
- WF-47-JS03
- BMS-986260
- GNF2133